Sector
PharmaceuticalsOpen
₹151.65Prev. Close
₹151.65Turnover(Lac.)
₹6.08Day's High
₹151.75Day's Low
₹147.952 Week's High
₹23052 Week's Low
₹122Book Value
₹95.04Face Value
₹10Mkt Cap (₹ Cr.)
88.51P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.9 | 5.9 | 4.92 | 4.92 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 45.55 | 52.38 | 45.38 | 44.7 |
Net Worth | 51.45 | 58.28 | 50.3 | 49.62 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 44.34 | 51.3 | 55.94 | 58.13 |
yoy growth (%) | -13.56 | -8.29 | -3.75 | -5.33 |
Raw materials | -22.46 | -29.5 | -35.91 | -34.69 |
As % of sales | 50.65 | 57.51 | 64.2 | 59.68 |
Employee costs | -7.63 | -7.83 | -6.28 | -6.62 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -2.07 | 0.24 | 4.23 | 4.55 |
Depreciation | -4.19 | -1.98 | -1.57 | -1.07 |
Tax paid | 0.45 | -0.37 | -1.17 | -1.63 |
Working capital | 0.97 | -2.97 | 1.06 | -1.99 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -13.56 | -8.29 | -3.75 | -5.33 |
Op profit growth | 21.46 | -39.3 | -14.22 | 17.01 |
EBIT growth | -150.95 | -79.27 | -4.77 | 26.16 |
Net profit growth | 1,205.81 | -104.04 | -17.37 | 60.43 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 120.75 | 104.39 | 101.28 | 126.63 | 68.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 120.75 | 104.39 | 101.28 | 126.63 | 68.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 11.89 | 1.53 | 2.28 | 3.19 | 0.96 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.65 | 92.31 | 3,95,326.43 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,537.95 | 78.57 | 1,73,562.03 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,498.35 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,312.75 | 20.48 | 1,09,550.72 | 1,200.7 | 0.61 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,226.65 | 57.31 | 1,09,199.59 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
R K P Verma
Independent Non Exe. Director
Dipti Shah
Independent Non Exe. Director
Vishal Jain
Non-Exec & Non-Independent Dir
Prashant Godha
Whole-time Director
Saahil U Parikh
Whole-time Director
Nilesh Jain
Company Sec. & Compli. Officer
Piyush Ajmera
54 D Kandivli Industrial Estat,
Charkop Kandivli (West),
Maharashtra - 400067
Tel: 91-22-2868 8544
Website: http://www.makerslabs.com
Email: investors@makerslabs.com; makers@makerslabs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Compan...
Read More
Reports by Makers Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.